Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A New Prenatal Blood Test for Down Syndrome (RNA)

This study has been completed.
Sequenom, Inc.
Information provided by (Responsible Party):
Glenn E. Palomaki PhD, Women and Infants Hospital of Rhode Island Identifier:
First received: April 6, 2009
Last updated: June 1, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by Identifier (NCT Number):